Symmetry Partners LLC Lowers Stake in Senseonics Holdings, Inc. Common Stock $SENS

Symmetry Partners LLC cut its position in Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) by 95.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 23,385 shares of the company’s stock after selling 444,330 shares during the quarter. Symmetry Partners LLC’s holdings in Senseonics Holdings, Inc. Common Stock were worth $129,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of SENS. HBK Sorce Advisory LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the 3rd quarter valued at $39,000. Goldstone Financial Group LLC purchased a new stake in Senseonics Holdings, Inc. Common Stock in the 3rd quarter worth $52,000. UBS Group AG raised its holdings in Senseonics Holdings, Inc. Common Stock by 409.0% during the third quarter. UBS Group AG now owns 4,248,519 shares of the company’s stock valued at $1,852,000 after acquiring an additional 3,413,866 shares during the period. Vanguard Group Inc. lifted its position in shares of Senseonics Holdings, Inc. Common Stock by 2.2% in the third quarter. Vanguard Group Inc. now owns 34,219,484 shares of the company’s stock valued at $14,920,000 after acquiring an additional 749,453 shares in the last quarter. Finally, Keynote Financial Services LLC lifted its position in shares of Senseonics Holdings, Inc. Common Stock by 1.5% in the third quarter. Keynote Financial Services LLC now owns 211,350 shares of the company’s stock valued at $92,000 after acquiring an additional 3,065 shares in the last quarter. 12.36% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CEO Timothy T. Goodnow bought 17,225 shares of the stock in a transaction dated Friday, March 13th. The stock was purchased at an average cost of $5.79 per share, for a total transaction of $99,732.75. Following the transaction, the chief executive officer owned 651,243 shares of the company’s stock, valued at $3,770,696.97. The trade was a 2.72% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Douglas A. Roeder bought 17,500 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was acquired at an average cost of $5.73 per share, with a total value of $100,275.00. Following the completion of the acquisition, the director owned 119,731 shares of the company’s stock, valued at $686,058.63. This represents a 17.12% increase in their position. The SEC filing for this purchase provides additional information. 3.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research firms recently issued reports on SENS. TD Cowen reiterated a “buy” rating on shares of Senseonics Holdings, Inc. Common Stock in a research report on Thursday, January 8th. Weiss Ratings assumed coverage on Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, February 17th. They issued a “sell (d-)” rating for the company. Finally, Stifel Nicolaus set a $9.00 price objective on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $18.38.

Senseonics Holdings, Inc. Common Stock Price Performance

Shares of Senseonics Holdings, Inc. Common Stock stock opened at $6.77 on Monday. The stock has a market capitalization of $282.92 million, a price-to-earnings ratio of -4.01 and a beta of 1.04. The firm’s 50-day moving average price is $6.86. The company has a current ratio of 4.83, a quick ratio of 4.55 and a debt-to-equity ratio of 0.58. Senseonics Holdings, Inc. Common Stock has a twelve month low of $5.25 and a twelve month high of $15.74.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.